Stay updated with breaking news from Rating Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company"), today announced that its Marketing Authorisation Application (MAA) to the European Medicines Agency's (EMA) Committee for Medicinal
TORONTO, Jan. 12, 2022 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a company focused on the…
Learn everything you need to know about conducting performance appraisals.
PharmaTher Holdings announced that the U.S. FDA has accepted IND application to proceed with a Phase 2 clinical trial evaluating ketamine in the treatment of ALS
TORONTO, Jan. 12, 2022 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a company focused on the...